We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AGI:TSXAlamos Gold Inc. Analysis

Data as of 2026-03-11 - not real-time

CA$68.69

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Alamos Gold (AGI) is riding a strong bullish trend with the 20‑day SMA (66.66) comfortably below the current price of $68.69 and the 200‑day SMA (46.88) well beneath it, indicating long‑term upside. Revenue surged 53% to $1.81 B and operating margins are robust at 87%, while free cash flow topped $350 M, supporting a 60% dividend increase to $0.16 per share. The technical picture is mixed: MACD shows a bearish signal and a negative histogram, yet RSI sits at a neutral 56 and volume is increasing, suggesting momentum may still be intact. Valuation is a concern – the DCF fair value of $38.74 is far below the market price, implying the stock is currently overvalued despite a 15% upside/downside estimate. Recent multi‑year production guidance and an expansion study in the Island Gold district underline growth potential, but the high 30‑day volatility (≈78%) and modest beta (~0.27) add price swing risk.
Overall, AGI presents a solid growth story with sustainable dividends and strong balance‑sheet metrics, but investors should be cautious of the premium pricing and short‑term technical headwinds. A measured approach—holding or modest buying on dips—aligns with the current risk‑reward profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Mixed technical signals (bearish MACD, neutral RSI)
  • Current price above DCF fair value
  • Increasing volume supporting short‑term momentum

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong earnings growth and cash generation
  • Expansion plans through 2028 boosting future output
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust revenue growth and high operating margins
  • Low debt levels and strong balance sheet
  • Long‑term commodity exposure and diversified geography

Key Metrics & Analysis

Financial Health

Revenue Growth53.10%
Profit Margin48.97%
P/E Ratio24.0
ROE22.06%
ROA11.59%
Debt/Equity5.02
P/B Ratio4.8
Op. Cash FlowCA$795.3M
Free Cash FlowCA$413.8M

Technical Analysis

TrendBullish
RSI56.6
SupportCA$56.85
ResistanceCA$75.78
MA 20CA$66.66
MA 50CA$60.21
MA 200CA$46.88
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91

Valuation

Fair ValueCA$38.74
Target PriceCA$79.23
Upside/Downside15.35%
GradeOvervalued
TypeGrowth
Dividend Yield0.23%

Risk Assessment

Beta0.27
Volatility77.60%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.